Hims & Hers Stock Jumps After Novo Nordisk Deal. What It Means for Drugmaker [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Shares of Hims & Hers Health ( NYSE:HIMS ) climbed about 5% on Thursday morning after the telehealth company said it entered a collaboration with Novo Nordisk ( NYSE:NVO ) to offer the drugmaker's branded GLP-1 weight-loss treatments on its platform. Under the arrangement , Hims & Hers plans to provide Novo Nordisk's diabetes and obesity medications, including Ozempic (semaglutide) and Wegovy (semaglutide), beginning later in March. The drugs are widely used GLP-1 therapies that help regulate blood sugar and appetite, supporting treatment for diabetes and chronic weight management. Warning! GuruFocus has detected 6 Warning Signs with HIMS. Is HIMS fairly valued? Test your thesis with our free DCF calculator. As part of the collaboration, Hims & Hers said it will discontinue marketing its compounded GLP-1 products across its platform and promotional channels. Compounded medications are customized formulations prepared by pharmacies wh
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMSPR Newswire
- Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights [Yahoo! Finance]Yahoo! Finance
- UnitedHealth, Hims & Hers, Gambling.Com - Value Investing With Raul Shah [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. Investigated by the Portnoy Law FirmGlobeNewswire
- Hims And Hers Health Pushes Into Complex Care And Global Growth [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 2/23/26 - Beat
HIMS
Sec Filings
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- HIMS's page on the SEC website